Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide

Anesthesiology

Volumn 90, Issue 1, 1999, Pages 24-35

  Szenohradszky, Janos ^a,b,d   Caldwell, James E ^a,d   Wright, Peter M C ^a,c,d   Brown, Ronald ^d   Lau, Marie ^d   Luks, Andrew M ^d   Fisher, Dennis M ^a,d  

^a Department of Anesthesia ^*  (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug metabolism; Mixed effects modeling; Muscle relaxants; ORG9487; Rapacuronium

Indexed keywords

DRUG DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; RAPACURONIUM; VECURONIUM;

ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL MODEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; SKELETAL MUSCLE;

ADOLESCENT; ADULT; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 0032615583     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199901000-00006     Document Type: Article

References (23)

1. Kahwaji R, Bevan DR, Bikhazi G, Shanks CA, Fragen RJ, Dyck JB, Angst MS, Matteo R: Dose-ranging study in younger adult and elderly patients of ORG 9487, a new, rapid-onset, short-duration muscle relaxant. Anesth Analg 1997; 84:1011-8
2. Miller RD, Cullen DJ: Renal failure and postoperative respiratory failure: Recurarization? Br J Anaesth 1976; 48:253-6
3. McLeod K, Watson MJ, Rawlins MD: Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Br J Anaesth 1976; 48:341-5
4. Buzello W, Agoston S: Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Anaesthesist 1978; 27:291-7
5. Fahey MR, Morris RB, Miller RD, Nguyen T-L, Upton RA: Pharmacokinetics of Org NC45 (Norcuron) in patients with and without renal failure. Br J Anaesth 1981; 53:1049-53
6. Fahey MR, Rupp SM, Fisher DM, Miller RD, Sharma M, Canfell C, Castagnoli K, Hennis PJ: The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. ANESTHESIOLOGY 1984; 61:699-702
7. Cook DR, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, Harrelson JC, Welch RM, Samara B: Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 1992; 69:580-5
8. Szenohradszky J, Fisher DM, Segredo V, Caldwell JE, Bragg P, Sharma ML, Gruenke LD, Miller RD: Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. ANESTHESIOLOGY 1992; 77: 899-904
9. Szenohradszky J, Caldwell JE, Sharma ML, Gruenke LD, Miller RD: Interaction of rocuronium (ORG 9426) and phenytoin in a patient undergoing cadaver renal transplantation: A possible pharmacokinetic mechanism? ANESTHESIOLOGY 1994; 80:1167-70
10. Lee GC, Iyengar S, Szenohradszky J, Caldwell JE, Wright PM, Brown R, Lau M, Luks A, Fisher DM: Improving the design of muscle relaxant studies. Stabilization period and tetanic recruitment. ANESTHESIOLOGY 1997; 86:48-54
11. Beal SL, Sheiner LB: Methodology of population pharmacokinetics, Drug Fate and Metabolism: Methods and Techniques. Edited by E Garrett, J Hirtz. New York, Marcel Dekker, 1985, pp 135-83
12. Fleck C, Borner A, Kretzschmar M, Machnik G, Sprott H, Zimmermann T, Keil E, Braunlich H: Liver function after bilateral nephrectomy. Liver 1992; 12:319-25
13. Laganiere S, Shen DD: Altered S(-)-propranolol disposition in bilateral ureter-ligated rats. Nephron 1987; 46:305-11
14. Terao N, Shen DD: Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood. J Pharmacol Exp Ther 1985; 233:277-84
15. Touchette MA, Slaughter RL: The effect of renal failure on hepatic drug clearance. DICP: Ann Pharmacother 1991; 25:1214-24
16. Schiere S, Proost JH, Wierda JMKH: Pharmacokinetics and pharmacokinetic/pharmacodynamic (PK/PD) relationship of ORG 9488, the 3-desacetyl metabolite of ORG 9487 (abstract). ANESTHESIOLOGY 1997; 87:A377
17. Wright PMC, Brown R, Lau M, Fisher DM: A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide. ANESTHESIOLOGY 1999; 90:16-23
18. Bowman W, Rodger I, Houston J, Marshall R, McIndewar I: Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. ANESTHESIOLOGY 1988; 69:57-62
19. Kopman AF: Pancuronium, gallamine, and d-tubocurarine compared: Is speed of onset inversely related to drug potency? ANESTHESIOLOGY 1989; 70:915-20
20. Caldwell JE, Lau M, Fisher DM: Atracurium versus vecuronium in asthmatic patients. A blinded, randomized comparison of adverse events. ANESTHESIOLOGY 1995; 83:986-91
21. Wright PMC, Hart P, Lau M, Sharma ML, Gruenke L, Fisher DM: Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study. ANESTHESIOLOGY 1994; 81:59-68
22. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD: Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327:524-8
23. Bates DM, Watts DG: Nonlinear Regression Analysis and Its Applications. New York, Wiley, 1988, pp 200-31